Arcutis Biotherapeutics, Inc. (ARQT)
NASDAQ: ARQT · Real-Time Price · USD
27.35
+0.02 (0.07%)
Jul 24, 2026, 4:00 PM EDT - Market closed
Arcutis Biotherapeutics Market Cap
Arcutis Biotherapeutics has a market cap or net worth of $3.42 billion as of July 24, 2026. Its market cap has increased by 92.48% in one year.
Market Cap
3.42B
Enterprise Value
3.31B
1-Year Change
92.48%
Ranking
Category
Stock Price
$27.35
ChartMarket Cap Chart
Since January 31, 2020, Arcutis Biotherapeutics's market cap has increased from $782.04M to $3.42B, an increase of 337.45%. That is a compound annual growth rate of 25.57%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 3.42B | -3.83% |
| Dec 31, 2025 | 3.56B | 118.17% |
| Dec 31, 2024 | 1.63B | 434.82% |
| Dec 29, 2023 | 304.85M | -66.18% |
| Dec 30, 2022 | 901.45M | -13.58% |
| Dec 31, 2021 | 1.04B | -14.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 31, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Parabilis Medicines | 3.98B |
| Tango Therapeutics | 3.85B |
| Enliven Therapeutics | 3.70B |
| Denali Therapeutics | 3.67B |
| Arcus Biosciences | 3.57B |
| Alumis | 3.57B |
| Structure Therapeutics | 3.49B |
| Telix Pharmaceuticals | 3.48B |